Assembling the jigsaw puzzle: CBX2 isoform 2 and its targets in disorders/differences of sex development

Carregando...
Imagem de Miniatura
Citações na Scopus
16
Tipo de produção
article
Data de publicação
2018
Título da Revista
ISSN da Revista
Título do Volume
Editora
WILEY
Autores
SPROLL, Patrick
EID, Wassim
GOMES, Camila R.
BIASON-LAUBER, Anna
Citação
MOLECULAR GENETICS & GENOMIC MEDICINE, v.6, n.5, p.785-795, 2018
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundOne of the defining moments of human life occurs early during embryonic development, when individuals sexually differentiate into either male or female. Perturbation of this process can lead to disorders/differences of sex development (DSD). Chromobox protein homolog 2 (CBX2) has two distinct isoforms, CBX2.1 and CBX2.2: the role of CBX2.1 in DSD has been previously established, yet to date the function of the smaller isoform CBX2.2 remains unknown. MethodsThe genomic DNA of two 46,XY DSD patients was analysed using whole exome sequencing. Furthermore, protein/DNA interaction studies were performed using DNA adenine methyltransferase identification (DamID) to identify putative binding partners of CBX2. Finally, invitro functional studies were used to elucidate the effect of wild-type and variant CBX2.2 on selected downstream targets. ResultsHere, we describe two patients with features of DSD i.e. atypical external genitalia, perineal hypospadias and no palpable gonads, each patient carrying a distinct CBX2.2 variant, p.Cys132Arg (c.394T>C) and p.Cys154fs (c.460delT). We show that both CBX2.2 variants fail to regulate the expression of genes essential for sexual development, leading to a severe 46,XY DSD defect, likely because of a defective expression of EMX2 in the developing gonad. ConclusionOur study indicates a distinct function of the shorter form of CBX2 and by identifying several of its unique targets, can advance our understanding of DSD pathogenesis and ultimately DSD diagnosis and management.
Palavras-chave
CBX2, DamID, DSD, EMX2, gonad development
Referências
  1. Baetens D, 2017, GENET MED, V19, P367, DOI 10.1038/gim.2016.118
  2. Bhoj EJ, 2011, EUR J HUM GENET, V19, P540, DOI 10.1038/ejhg.2010.245
  3. Biason-Lauber A, 2009, AM J HUM GENET, V84, P658, DOI 10.1016/j.ajhg.2009.03.016
  4. Daftary GS, 2004, J CLIN ENDOCR METAB, V89, P2390, DOI 10.1210/jc.2003-031389
  5. Eid W, 2015, MOL ENDOCRINOL, V29, P247, DOI 10.1210/me.2014-1339
  6. Eid W, 2010, EMBO REP, V11, P962, DOI 10.1038/embor.2010.157
  7. Galli R, 2002, DEVELOPMENT, V129, P1633
  8. Gangemi RMR, 2001, MECH DEVELOP, V109, P323, DOI 10.1016/S0925-4773(01)00546-9
  9. Granata T, 1997, NEUROLOGY, V48, P1403, DOI 10.1212/WNL.48.5.1403
  10. Heins N, 2001, MOL CELL NEUROSCI, V18, P485, DOI 10.1006/mcne.2001.1046
  11. Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI 10.1136/adc.2006.098319
  12. Kaimal V, 2010, NUCLEIC ACIDS RES, V38, pW96, DOI 10.1093/nar/gkq418
  13. Katoh-Fukui Y, 1998, NATURE, V393, P688, DOI 10.1038/31482
  14. Katoh-Fukui Y, 2005, BLOOD, V106, P1612, DOI 10.1182/blood-2004-08-3367
  15. Katoh-Fukui Y, 2012, ENDOCRINOLOGY, V153, P913, DOI 10.1210/en.2011-1055
  16. Knower KC, 2007, SEX DEV, V1, P114, DOI 10.1159/000100033
  17. Kusaka M, 2010, ENDOCRINOLOGY, V151, P5893, DOI 10.1210/en.2010-0915
  18. Liang JJ, 2007, J UROLOGY, V177, P1918, DOI 10.1016/j.juro.2007.01.017
  19. MATSUSHIME H, 1990, MOL CELL BIOL, V10, P2261, DOI 10.1128/MCB.10.5.2261
  20. Miyamoto N, 1997, DEVELOPMENT, V124, P1653
  21. Morgan EA, 2003, DEVELOPMENT, V130, P3095, DOI 10.1242/dev.00530
  22. Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179
  23. O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010
  24. Ostrer H, 2007, SEX DEV, V1, P286, DOI 10.1159/000108930
  25. Piard J, 2014, AM J MED GENET A, V164, P2618, DOI 10.1002/ajmg.a.36662
  26. Scott V, 2005, J BIOCHEM, V137, P671, DOI 10.1093/jb/mvi086
  27. Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
  28. Shiota M, 2010, ONCOGENE, V29, P237, DOI 10.1038/onc.2009.322
  29. SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x
  30. Theil T, 2002, DEVELOPMENT, V129, P3045
  31. Troy PJ, 2003, MOL CELL BIOL, V23, P1, DOI 10.1128/MCB.23.1.1-13.2003
  32. Vogel MJ, 2007, NAT PROTOC, V2, P1467, DOI 10.1038/nprot.2007.148
  33. Vogel MJ, 2006, GENOME RES, V16, P1493, DOI 10.1101/gr.5391806
  34. Wilhelm D, 2002, GENE DEV, V16, P1839, DOI 10.1101/gad.220102